Canadian IBD Today

Current Issue

Special Supplement, May 2023

issue cover

Published: 2023-05-11

Articles

Targeting IL23p19 using risankizumab for the management of moderate-to-severly activ Crohn's disease: The next frontier?

Christopher Ma, MD, MPH, FRCPC
- PDF (en)

View All Issues